Progression pattern and adverse events with bevacizumab in glioblastoma.
Mamo A, Baig A, Azam M, Rho YS, Sahebjam S, Muanza T, Owen S, Petrecca K, Guiot MC, Al-Shami J, Sharma R, Kavan P.
Mamo A, et al. Among authors: kavan p.
Curr Oncol. 2016 Oct;23(5):e468-e471. doi: 10.3747/co.23.3108. Epub 2016 Oct 25.
Curr Oncol. 2016.
PMID: 27803607
Free PMC article.